Bachem

Bachem Holding AG is a biotechnology business based in Switzerland that operates in the areas of chemistry, biochemistry, and pharmaceuticals.

Bachem specializes in the creation of peptide-based biochemicals as well as the development of manufacturing procedures for these compounds, as well as the commercial manufacture of peptides and complex organic compounds as active medicinal components.

It is a wholly owned subsidiary of Ingro Finanz AG and was established in 1971. The headquarters are located in Bubendorf, which is in the canton of Basel-Landschaft. Production facilities are located in Vionnaz, which is in the canton of Valais, as well as in the cities of Vista and Torrance in the state of California, as well as in St. Helens, which is close to Liverpool, in Great Britain. Sales and distribution are handled out of Tokyo.

Bachem had 1057 workers, revenue of CHF 261.6 million, and a net income of CHF 41.8 million as of the end of 2017.

Founded: 1971

Headquarters: Bubendorf, Switzerland

Website: https://www.bachem.com/